164 related articles for article (PubMed ID: 19904443)
1. Newborn screening for all identifiable disorders with tandem mass spectrometry is cost effective: supporting arguments.
Therrell BL; Buechner C
Ann Acad Med Singap; 2008 Dec; 37(12 Suppl):32-4. PubMed ID: 19904443
[TBL] [Abstract][Full Text] [Related]
2. Newborn screening for all identifiable disorders with tandem mass spectrometry is cost effective: the negative case.
Wilcken B
Ann Acad Med Singap; 2008 Dec; 37(12 Suppl):36-3. PubMed ID: 19904444
[TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.
Pandor A; Eastham J; Beverley C; Chilcott J; Paisley S
Health Technol Assess; 2004 Mar; 8(12):iii, 1-121. PubMed ID: 14982654
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model.
Cipriano LE; Rupar CA; Zaric GS
Value Health; 2007; 10(2):83-97. PubMed ID: 17391418
[TBL] [Abstract][Full Text] [Related]
5. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y
PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410
[TBL] [Abstract][Full Text] [Related]
6. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
[TBL] [Abstract][Full Text] [Related]
7. Newborn screening for inborn errors of metabolism: a systematic review.
Seymour CA; Thomason MJ; Chalmers RA; Addison GM; Bain MD; Cockburn F; Littlejohns P; Lord J; Wilcox AH
Health Technol Assess; 1997; 1(11):i-iv, 1-95. PubMed ID: 9483156
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and cost-effectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry.
Tran K; Banerjee S; Li H; Noorani HZ; Mensinkai S; Dooley K
Clin Biochem; 2007 Feb; 40(3-4):235-41. PubMed ID: 17222812
[TBL] [Abstract][Full Text] [Related]
9. Inborn errors of metabolism and expanded newborn screening: review and update.
Mak CM; Lee HC; Chan AY; Lam CW
Crit Rev Clin Lab Sci; 2013 Nov; 50(6):142-62. PubMed ID: 24295058
[TBL] [Abstract][Full Text] [Related]
10. Cost-benefit analysis: newborn screening for inborn errors of metabolism in Lebanon.
Khneisser I; Adib S; Assaad S; Megarbane A; Karam P
J Med Screen; 2015 Dec; 22(4):182-6. PubMed ID: 26062758
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of tandem mass spectrometry newborn screening in Australia.
Norman R; Haas M; Chaplin M; Joy P; Wilcken B
Pediatrics; 2009 Feb; 123(2):451-7. PubMed ID: 19171609
[TBL] [Abstract][Full Text] [Related]
12. Inborn Error of Metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI/MS/MS): An 8 year journey from pilot to current program.
Lim JS; Tan ES; John CM; Poh S; Yeo SJ; Ang JS; Adakalaisamy P; Rozalli RA; Hart C; Tan ET; Ranieri E; Rajadurai VS; Cleary MA; Goh DL
Mol Genet Metab; 2014; 113(1-2):53-61. PubMed ID: 25102806
[TBL] [Abstract][Full Text] [Related]
13. Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.
Schoen EJ; Baker JC; Colby CJ; To TT
Pediatrics; 2002 Oct; 110(4):781-6. PubMed ID: 12359795
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and therapeutic monitoring of inborn errors of metabolism in 100,077 newborns from Jining city in China.
Yang CJ; Wei N; Li M; Xie K; Li JQ; Huang CG; Xiao YS; Liu WH; Chen XG
BMC Pediatr; 2018 Mar; 18(1):110. PubMed ID: 29534692
[TBL] [Abstract][Full Text] [Related]
15. Expanded newborn screening and confirmatory follow-up testing for inborn errors of metabolism detected by tandem mass spectrometry.
Ozben T
Clin Chem Lab Med; 2013 Jan; 51(1):157-76. PubMed ID: 23183752
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of newborn screening by tandem mass spectrometry in Shenzhen, China: value and affordability of new screening technology.
Yu M; Xu J; Song X; Du J
BMC Health Serv Res; 2022 Aug; 22(1):1039. PubMed ID: 35971172
[TBL] [Abstract][Full Text] [Related]
17. Expanded newborn screening using tandem mass spectrometry.
Fearing MK; Levy HL
Adv Pediatr; 2003; 50():81-111. PubMed ID: 14626484
[No Abstract] [Full Text] [Related]
18. Application of mass spectrometry in newborn screening: about both small molecular diseases and lysosomal storage diseases.
Hwu WL; Chien YH; Lee NC; Wang SF; Chiang SC; Hsu LW
Top Curr Chem; 2014; 336():177-96. PubMed ID: 22911488
[TBL] [Abstract][Full Text] [Related]
19. Inborn errors of metabolism detectable by tandem mass spectrometry in Egypt: The first newborn screening pilot study.
Hassan FA; El-Mougy F; Sharaf SA; Mandour I; Morgan MF; Selim LA; Hassan SA; Salem F; Oraby A; Girgis MY; Mahmoud IG; El-Badawy A; El-Nekhely I; Moharam N; Mehaney DA; Elmonem MA
J Med Screen; 2016 Sep; 23(3):124-9. PubMed ID: 26790708
[TBL] [Abstract][Full Text] [Related]
20. Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening Panel.
Insinga RP; Laessig RH; Hoffman GL
J Pediatr; 2002 Oct; 141(4):524-31. PubMed ID: 12378192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
